This remarkable project sequences 100,000 genomes from circa 85,000 patients affected by rare disorders and cancers – making the UK a world leader in genomic medicine.
Advances in technology mean that researchers can now move beyond single-gene analysis for complex conditions to now simultaneously analysing a far greater number of genes. Such genomic research offers us the prospect of genomic healthcare and perhaps even medicine tailored to our individual needs.
The 100,000 Genomes Project accelerates this research and provides much-needed data that will allow far better clinical interpretation of the genetic code.
The Project’s impact since its launch in 2013 is remarkable: it has brought life-changing results to NHS England patients and introduced genomic medicine to our health service, making the NHS the first national healthcare system in the world to offer whole genome sequencing in routine care.
Watch Professor Sir Mark Caulfield, Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry, and Professor of Clinical Pharmacology, explain more about the project:
Read more about the 100,000 Genomes project